20 results
424B3
PROK
ProKidney Corp - Ordinary Shares
21 Apr 23
Prospectus supplement
4:18pm
any clinical trials, need to be redesigned, recruit and enroll subjects on time or be completed on schedule, or at all. Clinical trials can be delayed … ;
the design of the trial;
our ability to recruit clinical trial investigators with the appropriate competencies and experience;
clinicians
POS AM
PROK
ProKidney Corp - Ordinary Shares
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
for the approval of REACT. We may experience delays in conducting any clinical trials, need to be redesigned, recruit and enroll subjects on time … for identifying patients;
the proximity of subjects to clinical trial sites;
the design of the trial;
our ability to recruit clinical trial investigators
424B3
PROK
ProKidney Corp - Ordinary Shares
9 Sep 22
Prospectus supplement
5:05pm
may experience delays in conducting any clinical trials, need to be redesigned, recruit and enroll subjects on time or be completed on schedule … be implemented, and other factors;
the proximity of subjects to clinical trial sites;
the design of the trial;
our ability to recruit clinical
DEFM14A
hreh3uojhr0w36xxelaf
10 Jun 22
Proxy related to merger
4:54pm
DEFA14A
qxxtntjrzulvxt8
7 Jun 22
Additional proxy soliciting materials
4:31pm
PRER14A
6vkoo1lo37xon642t8rz
11 Apr 22
Preliminary revised proxy
5:29pm
PREM14A
wmz3u2cou
14 Feb 22
Preliminary proxy related to merger
4:55pm
DEFA14A
056n2usscbg nbut4
18 Jan 22
Additional proxy soliciting materials
7:14am
8-K
EX-99.2
61akmekr7irwn
18 Jan 22
Entry into a Material Definitive Agreement
7:05am
424B4
rr039zkp9eki0wbyas
1 Jul 21
Prospectus supplement with pricing info
5:20pm
S-1
4f89n j41l3
2 Jun 21
IPO registration
5:17pm
DRS
6te6 e6may31o
21 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next